Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.

Song, Hao; Zhang, Jinna; Ning, Liang; Zhang, Honglai; Chen, Dong; Jiao, Xuelong; Zhang, Kejun

Song, Hao; Zhang, Jinna; Ning, Liang; Zhang, Honglai; Chen, Dong; Jiao, Xuelong; Zhang, Kejun.

Afiliación

Song H; Department of Radiotherapy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Zhang J; Department of Thyroid Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Ning L; Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Zhang H; Department of Thyroid Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Chen D; Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Jiao X; Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Zhang K; Department of Thyroid Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).

Med Sci Monit ; 28: e936571, 2022 03 07.

Article en En | MEDLINE | ID: mdl-35250023

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Med Sci Monit Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google